| Symbol | NSRX |
|---|---|
| Name | NASUS PHARMA LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 29 HARAKEVET ST, TEL AVIV - YAFO, L3 6618003 |
| Telephone | 972 54-255-3956 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002029039 |
| Description | None |
New Form SCHEDULE 13G - Nasus Pharma Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001193125-26-225115 <b>Size:</b> 141 KB
Read moreDirector Teleman Dan Benjamin 🟢 acquired 2.9K shares of Nasus Pharma Ltd (NSRX) at $3.76 Transaction Date: Apr 22, 2026 | Filing ID: 018607
Read moreNew Form SCHEDULE 13G - Nasus Pharma Ltd <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0002073679-26-000045 <b>Size:</b> 101 KB
Read moreDirector Teleman Dan Benjamin 🟢 acquired 15.0K shares of Nasus Pharma Ltd (NSRX) at $2.04 Transaction Date: Mar 31, 2026 | Filing ID: 014503
Read moreNew Form EFFECT - Nasus Pharma Ltd <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 9999999995-26-001019 <b>Size:</b> 1 KB
Read moreNew Form 3 - Nasus Pharma Ltd <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001493152-26-013399 <b>Size:</b> 6 KB
Read moreNew Form 3 - Nasus Pharma Ltd <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001493152-26-013389 <b>Size:</b> 5 KB
Read moreNew Form 3 - Nasus Pharma Ltd <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001493152-26-013388 <b>Size:</b> 4 KB
Read moreNew Form 3 - Nasus Pharma Ltd <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0001493152-26-013385 <b>Size:</b> 4 KB
Read more